Abstract B130: The intratumoral heterogeneity of glioblastoma suggests a pivotal role for clonal evolution.

Hoon Kim(Seoul National University), Roeland Verhaak(Broad Institute), Eric S. Lander(Broad Institute), Mark L. Cohen(University Hospitals Cleveland Medical Center), Peter W. Laird(Van Andel Institute), John N. Weinstein(The University of Texas MD Anderson Cancer Center), Gaddy Getz(Broad Institute), Jill S. Barnholtz‐Sloan(Emory University), Matthew Meyerson(Broad Institute), Lisa Scarpace, Stacey Gabriel(Broad Institute), Tom Mikkelsen(Henry Ford Health System), Erwin G. Van Meir(University of Alabama at Birmingham), Daniel J. Brat(Northwestern University), Carrie Sougnez(Broad Institute), Jonna Grimsby(Broad Institute), Andrew E. Sloan(University of Southern California), Lynda Chin(American Productivity and Quality Center), Selene Virk(The University of Texas MD Anderson Cancer Center), Seyed S. Amini(The University of Texas MD Anderson Cancer Center), Siyuan Zheng(Third Affiliated Hospital of Guangzhou Medical University)
Molecular Cancer Therapeutics
November 1, 2013
Cited by 0


Related Papers